GPC3 is the most commonly used IHC marker to distinguish well-differentiated HCCs from other benign liver tumours.24,25 Our results indicate that both AFP RNAscope and GPC3 performed well when distinguishing HCC from FNH and LA, as they both were negative in FNH and LA. This evidence concerns the gene AFP and hepatocellular carcinoma.